Jemma Hopewell is Professor of Precision Medicine and Epidemiology at the Clinical Trial Service Unit, Nuffield Department of Population Health, University of Oxford, and a British Heart Foundation Research Fellow.
Professor Hopewell directs a multidisciplinary team in a translational research programme that leverages genetic information and other big data from large-scale clinical trials and observational cohorts to investigate the causes and treatments for cardiovascular disease and arrhythmias, understand predictors of risk and response to treatment, and inform patient care. Her work capitalises on the synergy between comprehensive healthcare data sources and powerful analytical approaches, through which biological and clinical insights can be made.

She has contributed to the conduct of a number of large-scale clinical trials of lipid modification, played leading roles in international genetic consortia and holds various positions on scientific committees that focus on therapeutic development, precision medicine, and population health.


Proteomics in cardiovascular diseaseWebinars on-demand(AtherothrombosisProteomicsCV risk factors: Others)